Could genetic polymorphisms related to oxidative stress modulate effects of heavy metals for risk of human preterm birth?

Reproductive Toxicology

Volumn 42, Issue , 2013, Pages 24-26

  Shachar, Bat Zion ^a   Carmichael, Suzan L ^a   Stevenson, David K ^a   Shaw, Gary M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic polymorphisms; Heavy metals; Oxidative stress; Preterm birth

Indexed keywords

ARSENIC; ARYLDIALKYLPHOSPHATASE 1; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE T1; HEAVY METAL; HEME OXYGENASE 1; LEAD; MATRIX METALLOPROTEINASE; MERCURY; REACTIVE OXYGEN METABOLITE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; DETOXIFICATION; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LIPID METABOLISM; MATERNAL SMOKING; OXIDATIVE STRESS; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL EXPOSURE; REPRODUCTION; RISK ASSESSMENT; RISK FACTOR;

GENETIC POLYMORPHISMS; HEAVY METALS; OXIDATIVE STRESS; PRETERM BIRTH;

ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; METALS, HEAVY; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PREGNANCY; PREMATURE BIRTH;

EID: 84881250329     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.06.072     Document Type: Article

References (53)

1. Goldenberg R.L. The management of preterm labor. Obstetrics & Gynecology 2002, 100(5 (Pt 1)):1020-1037.
2. Wang X., Zuckerman B., Kaufman G., Wise P., Hill M., Niu T., et al. Molecular epidemiology of preterm delivery: methodology and challenges. Paediatric and Perinatal Epidemiology 2001, 15(Suppl. 2):63-77.
3. Preterm Birth: Causes, Consequences, and Prevention 2007, The National Academy Press, Washington, DC. R.E. Behrman, A.S. Butler (Eds.).
4. Wilhelm M., Ritz B. Local variations in CO and particulate air pollution and adverse birth outcomes in Los Angeles County, California, USA. Environmental Health Perspectives 2005, 113(9):1212-1221.
5. Longnecker M.P., Klebanoff M.A., Zhou H., Brock J.W. Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth. Lancet 2001, 358(9276):110-114.
6. Flood K., Malone F.D. Prevention of preterm birth. Seminars in Fetal & Neonatal Medicine 2012, 17(1):58-63.
7. Gundacker C., Hengstschlager M. The role of the placenta in fetal exposure to heavy metals. Wiener medizinische Wochenschrift 2012, 162(9/10):201-206.
8. ATSDR Priority list of hazardous substances for 2007, 2010 2010, CERCLA. Centers for Disease Control, Atlanta, GA.
9. Ni Z., Hou S., Barton C.H., Vaziri N.D. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney International 2004, 66(6):2329-2336.
10. Schober S.E., Mirel L.B., Graubard B.I., Brody D.J., Flegal K.M. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environmental Health Perspectives 2006, 114(10):1538-1541.
11. Hayes R.B. The carcinogenicity of metals in humans. Cancer Causes Control 1997, 8(3):371-385.
12. Vigeh M., Yokoyama K., Seyedaghamiri Z., Shinohara A., Matsukawa T., Chiba M., et al. Blood lead at currently acceptable levels may cause preterm labour. Occupational and Environmental Medicine 2011, 68(3):231-234.
13. Jelliffe-Pawlowski L.L., Miles S.Q., Courtney J.G., Materna B., Charlton V. Effect of magnitude and timing of maternal pregnancy blood lead (Pb) levels on birth outcomes. Journal of Perinatology 2006, 26(3):154-162.
14. Committee on Obstetric P. Committee opinion no. 533: lead screening during pregnancy and lactation. Obstetrics & Gynecology 2012, 120(2 (Pt 1)):416-420.
15. Irgens A., Kruger K., Skorve A.H., Irgens L.M. Reproductive outcome in offspring of parents occupationally exposed to lead in Norway. American Journal of Industrial Medicine 1998, 34(5):431-437.
16. Torres-Sanchez L.E., Berkowitz G., Lopez-Carrillo L., Torres-Arreola L., Rios C., Lopez-Cervantes M. Intrauterine lead exposure and preterm birth. Environmental Research 1999, 81(4):297-301.
17. Chuang H.Y., Schwartz J., Gonzales-Cossio T., Lugo M.C., Palazuelos E., Aro A., et al. Interrelations of lead levels in bone: venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environmental Health Perspectives 2001, 109(5):527-532.
18. Ramon R., Ballester F., Aguinagalde X., Amurrio A., Vioque J., Lacasana M., et al. Fish consumption during pregnancy: prenatal mercury exposure, and anthropometric measures at birth in a prospective mother-infant cohort study in Spain. The American Journal of Clinical Nutrition 2009, 90(4):1047-1055.
19. Lee B.E., Hong Y.C., Park H., Ha M., Koo B.S., Chang N., et al. Interaction between GSTM1/GSTT1 polymorphism and blood mercury on birth weight. Environmental Health Perspectives 2010, 118(3):437-443.
20. Rahman A., Vahter M., Smith A.H., Nermell B., Yunus M., El Arifeen S., et al. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. American Journal of Epidemiology 2009, 169(3):304-312.
21. Anwar-Mohamed A., Elbekai R.H., El-Kadi A.O. Regulation of CYP1A1 by heavy metals and consequences for drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 2009, 5(5):501-521.
22. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283(2/3):65-87.
23. Xia D., Yu X., Liao S., Shao Q., Mou H., Ma W. Protective effect of Smilax glabra extract against lead-induced oxidative stress in rats. Journal of Ethnopharmacology 2010, 130(2):414-420.
24. Malekirad A.A., Oryan S., Fani A., Babapor V., Hashemi M., Baeeri M., et al. Study on clinical and biochemical toxicity biomarkers in a zinc-lead mine workers. Toxicology and Industrial Health 2010, 26(6):331-337.
25. Burton G.J., Jauniaux E. Oxidative stress. Best Practice & Research Clinical Obstetrics & Gynaecology 2011, 25(3):287-299.
26. Clerici G., Slavescu C., Fiengo S., Kanninen T.T., Romanelli M., Biondi R., et al. Oxidative stress in pathological pregnancies. Journal of Obstetrics & Gynaecology 2012, 32(2):124-127.
27. Karacay O., Sepici-Dincel A., Karcaaltincaba D., Sahin D., Yalvac S., Akyol M., et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks of gestation. Diabetes Research and Clinical Practice 2010, 89(3):231-238.
28. Seidegard J., Ekstrom G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environmental Health Perspectives 1997, 105(Suppl. 4):791-799.
29. Goodrich J.M., Wang Y., Gillespie B., Werner R., Franzblau A., Basu N. Glutathione enzyme and selenoprotein polymorphisms associate with mercury biomarker levels in Michigan dental professionals. Toxicology and Applied Pharmacology 2011, 257(2):301-308.
30. Chung C.J., Huang C.Y., Pu Y.S., Shiue H.S., Su C.T., Hsueh Y.M. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype. Toxicology and Applied Pharmacology 2013, 266(2):254-259.
31. Gundacker C., Komarnicki G., Jagiello P., Gencikova A., Dahmen N., Wittmann K.J., et al. Glutathione-S-transferase polymorphism, metallothionein expression, and mercury levels among students in Austria. Science of the Total Environment 2007, 385(1-3):37-47.
32. Hsu L.I., Chen W.P., Yang T.Y., Chen Y.H., Lo W.C., Wang Y.H., et al. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. Journal of Biomedical Science 2011, 18:51.
33. Nukui T., Day R.D., Sims C.S., Ness R.B., Romkes M. Maternal/newborn GSTT1 null genotype contributes to risk of preterm: low birthweight infants. Pharmacogenetics 2004, 14(9):569-576.
34. Tsai H.J., Liu X., Mestan K., Yu Y., Zhang S., Fang Y., et al. Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on GxE interactions and pathogenic pathways. Human Genetics 2008, 123(4):359-369.
35. Li W.F., Sun C.W., Cheng T.J., Chang K.H., Chen C.J., Wang S.L. Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan. Toxicology and Applied Pharmacology 2009, 236(2):246-253.
36. Min J., Park H., Park B., Kim Y.J., Park J., Lee H., et al. Paraoxonase gene polymorphism and vitamin levels during pregnancy: relationship with maternal oxidative stress and neonatal birthweights. Reproductive Toxicology 2006, 22(3):418-424.
37. Gonzalvo M.C., Gil F., Hernandez A.F., Villanueva E., Pla A. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA: metals and mercurials. Chemico-Biological Interactions 1997, 105(3):169-179.
38. Li W.F., Pan M.H., Chung M.C., Ho C.K., Chuang H.Y. Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes. Environmental Health Perspectives 2006, 114(8):1233-1236.
39. Hernandez A.F., Gil F., Leno E., Lopez O., Rodrigo L., Pla A. Interaction between human serum esterases and environmental metal compounds. Neurotoxicology 2009, 30(4):628-635.
40. Chen D., Hu Y., Chen C., Yang F., Fang Z., Wang L., et al. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 2004, 15(4):466-470.
41. Baker A.M., Haeri S., Klein R.L., Boggess K. Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth. American Journal of Obstetrics & Gynecology 2010, 203(3):246e1-246e4.
42. Lee B.E., Park H., Park E.A., Gwak H., Ha E.H., Pang M.G., et al. Paraoxonase 1 gene and glutathione S-transferase mu 1 gene interaction with preterm delivery in Korean women. American Journal of Obstetrics & Gynecology 2010, 203(6):569e1-569e7.
43. Hernandez-Perez M., Mahalingam M. Matrix metalloproteinases in health and disease: insights from dermatopathology. The American Journal of Dermatopathology 2012, 34(6):565-579.
44. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2001, 21(7):1104-1117.
45. Xu P., Alfaidy N., Challis J.R. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. The Journal of Clinical Endocrinology & Metabolism 2002, 87(3):1353-1361.
46. Vu T.D., Yun F., Placido J., Reznik S.E. Placental matrix metalloproteinase-1 expression is increased in labor. Reproductive Sciences 2008, 15(4):420-424.
47. Sundrani D.P., Chavan-Gautam P.M., Pisal H.R., Mehendale S.S., Joshi S.R. Matrix metalloproteinase-1 and -9 in human placenta during spontaneous vaginal delivery and caesarean sectioning in preterm pregnancy. PLoS ONE 2012, 7(1):e29855.
48. Maymon E., Romero R., Pacora P., Gervasi M.T., Bianco K., Ghezzi F., et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. American Journal of Obstetrics & Gynecology 2000, 183(4):914-920.
49. Cockle J.V., Gopichandran N., Walker J.J., Levene M.I., Orsi N.M. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reproductive Sciences 2007, 14(7):629-645.
50. Jacob-Ferreira A.L., Lacchini R., Gerlach R.F., Passos C.J., Barbosa F., Tanus-Santos J.E. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury. Science of the Total Environment 2011, 409(20):4242-4246.
51. Jacob-Ferreira A.L., Passos C.J., Gerlach R.F., Barbosa F., Tanus-Santos J.E. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury. Science of the Total Environment 2010, 408(19):4085-4092.
52. Bainbridge S.A., Smith G.N. HO in pregnancy. Free Radical Biology & Medicine 2005, 38(8):979-988.
53. Muglia L.J., Katz M. The enigma of spontaneous preterm birth. The New England Journal of Medicine 2010, 362(6):529-535.